MAHENDRA SHAH
CIK 1255449 · last filed 2025-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$287.6K
Companies
6
Total Filings
27
Lifetime Open-Market Net
-$68.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$67.1K | 9 | 2025-10-08 |
| BOLT | Director | 71,532 | $4.02 | $287.6K | -$1.2K | 5 | 2024-06-14 |
| IPI Legacy Liquidation Co (IMPL) Delisted | Director | — | $0.24 | — | $0 | 3 | 2023-06-20 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 27,153 | — | — | $0 | 4 | 2018-06-18 |
| Q32 Bio Inc. (FIXX) Delisted | Director | 5,616 | $16.82 | $94.5K | $0 | 3 | 2018-05-16 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | 97,117 | — | — | $0 | 3 | 2017-05-09 |
Recent Filings · Page 2 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-28 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-13 | IPI Legacy Liquidation Co (IMPL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-05 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −10,680 | -$9.0K | EDGAR |
| 2021-02-09 | BOLT | Mixed | +1,434,001 | -$0 | EDGAR |
| 2021-02-03 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −10,800 | -$10.7K | EDGAR |
| 2018-06-18 | SOLENO THERAPEUTICS INC (SLNOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-16 | Q32 Bio Inc. (FIXX) Delisted | Grant (A) | +250,000 | $4.00M | EDGAR |
| 2018-04-04 | Q32 Bio Inc. (FIXX) Delisted | Mixed | +1,159,742 | $8.00M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.